[HTML][HTML] Deregulation of HLA-I in cancer and its central importance for immunotherapy

A Hazini, K Fisher, L Seymour - Journal for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
It is now well accepted that many tumors undergo a process of clonal selection which means
that tumor antigens arising at various stages of tumor progression are likely to be …

Immunostimulatory cancer-associated fibroblast subpopulations can predict immunotherapy response in head and neck cancer

A Obradovic, D Graves, M Korrer, Y Wang, S Roy… - Clinical Cancer …, 2022 - AACR
Purpose: Cancer-associated fibroblasts (CAF) have been implicated as potential mediators
of checkpoint immunotherapy response. However, the extensive heterogeneity of these cells …

Allogeneic natural killer cell therapy

MM Berrien-Elliott, MT Jacobs, TA Fehniger - Blood, 2023 - ashpublications.org
Interest in adoptive cell therapy for treating cancer is exploding owing to early clinical
successes of autologous chimeric antigen receptor (CAR) T lymphocyte therapy. However …

[HTML][HTML] Targeting immune dysfunction in aging

S Borgoni, KS Kudryashova, K Burka… - Ageing research …, 2021 - Elsevier
Human aging is a multifactorial phenomenon that affects numerous organ systems and
cellular processes, with the immune system being one of the most dysregulated …

[HTML][HTML] The changing role of natural killer cells in cancer metastasis

IS Chan, AJ Ewald - The Journal of clinical investigation, 2022 - Am Soc Clin Investig
Natural killer (NK) cells are innate immune cells that are critical to the body's antitumor and
antimetastatic defense. As such, novel therapies are being developed to utilize NK cells as …

Selenium‐containing nanoparticles combine the NK cells mediated immunotherapy with radiotherapy and chemotherapy

S Gao, T Li, Y Guo, C Sun, B Xianyu… - Advanced Materials, 2020 - Wiley Online Library
Considering the limited clinical benefits of individual approaches against malignancy,
natural killer (NK) cell‐mediated immunotherapy is increasingly utilized in combination with …

[HTML][HTML] Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells

T Kamiya, SV Seow, D Wong… - The Journal of …, 2019 - Am Soc Clin Investig
A key mechanism of tumor resistance to immune cells is mediated by expression of peptide-
loaded HLA class I molecule (HLA-E) in tumor cells, which suppresses NK cell activity via …

[HTML][HTML] NKG2A blockade potentiates CD8 T cell immunity induced by cancer vaccines

N van Montfoort, L Borst, MJ Korrer, M Sluijter… - Cell, 2018 - cell.com
Tumor-infiltrating CD8 T cells were found to frequently express the inhibitory receptor
NKG2A, particularly in immune-reactive environments and after therapeutic cancer …

[HTML][HTML] Covid-19: perspectives on innate immune evasion

N Taefehshokr, S Taefehshokr, N Hemmat… - Frontiers in …, 2020 - frontiersin.org
The ongoing outbreak of Coronavirus disease 2019 infection achieved pandemic status on
March 11, 2020. As of September 8, 2020 it has caused over 890,000 mortalities world-wide …

Human NK cells, their receptors and function

L Quatrini, M Della Chiesa, S Sivori… - European journal of …, 2021 - Wiley Online Library
NK cells are cytotoxic components of innate lymphoid cells (ILC) that provide a first line of
defense against viral infections and contribute to control tumor growth and metastasis. Their …